Menu
Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,145 | Dovepress* | 6,671+ | 1,347 | 8,018 | |
| PubMed Central* | 474 | 160 | 634 | ||
| Totals | 7,145 | 1,507 | 8,652 | ||
| *Since 14 October 2016 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar